ResearcherNankai UniversityNo recent work listed
Chao Jia
Matched on ORCID iD 0009-0000-4517-9217; OpenAlex author ID A5101604314. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2019: 1 paper · 2020: 4 papers
Papers 5
- Musashi2 promotes the progression of pancreatic cancer through a novel ISYNA1-p21/ZEB-1 pathway. Co-author DOI 10.1111/jcmm.15676↗
- Correction to: Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling. Co-author DOI 10.1186/s13046-020-01663-2↗
- Calreticulin promotes EMT in pancreatic cancer via mediating Ca2+ dependent acute and chronic endoplasmic reticulum stress. Co-author DOI 10.1186/s13046-020-01702-y↗
- Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling. Co-author DOI 10.1186/s13046-020-1521-4↗
- Preparation of Dual-Template Epitope Imprinted Polymers for Targeted Fluorescence Imaging and Targeted Drug Delivery to Pancreatic Cancer BxPC-3 Cells. Co-author DOI 10.1021/acsami.9b11533↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Rongxian Cao · 4 shared papers, 2020 · strength 0.43
- Paper Musashi2 promotes the progression of pancreatic cancer through a novel ISYNA1-p21/ZEB-1 pathway. DOI 10.1111/jcmm.15676↗
- Paper Correction to: Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling. DOI 10.1186/s13046-020-01663-2↗
- Paper Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling. DOI 10.1186/s13046-020-1521-4↗
- Guosen Wang · 4 shared papers, 2020 · strength 0.43
- Paper Musashi2 promotes the progression of pancreatic cancer through a novel ISYNA1-p21/ZEB-1 pathway. DOI 10.1111/jcmm.15676↗
- Paper Correction to: Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling. DOI 10.1186/s13046-020-01663-2↗
- Paper Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling. DOI 10.1186/s13046-020-1521-4↗
- Weiwei Sheng · 4 shared papers, 2020 · strength 0.43
- Paper Musashi2 promotes the progression of pancreatic cancer through a novel ISYNA1-p21/ZEB-1 pathway. DOI 10.1111/jcmm.15676↗
- Paper Correction to: Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling. DOI 10.1186/s13046-020-01663-2↗
- Paper Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling. DOI 10.1186/s13046-020-1521-4↗
- Ming Dong · 4 shared papers, 2020 · strength 0.43
- Paper Musashi2 promotes the progression of pancreatic cancer through a novel ISYNA1-p21/ZEB-1 pathway. DOI 10.1111/jcmm.15676↗
- Paper Correction to: Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling. DOI 10.1186/s13046-020-01663-2↗
- Paper Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling. DOI 10.1186/s13046-020-1521-4↗
- Jian Hua Sun · 3 shared papers, 2020 · strength 0.32
- Paper Correction to: Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling. DOI 10.1186/s13046-020-01663-2↗
- Paper Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling. DOI 10.1186/s13046-020-1521-4↗
- Paper Calreticulin promotes EMT in pancreatic cancer via mediating Ca2+ dependent acute and chronic endoplasmic reticulum str… DOI 10.1186/s13046-020-01702-y↗
- Qi Dong · 1 shared paper, 2020 · strength 0.11
- Lei Zhou · 1 shared paper, 2020 · strength 0.11
- Jianping Zhou · 1 shared paper, 2020 · strength 0.11
- Yukui Zhang · 1 shared paper, 2019 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.